ProPhase Labs, Inc. (PRPH) Social Stream
ProPhase Labs Inc (PRPH) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PRPH.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 1 | $5 | $5 | $5 | $8.13 | -38.5% |
| 2021-12-20 | 2 | $12 | $5 | $8.5 | $8.13 | 4.55% |
| 2022-02-16 | 2 | $15 | $5 | $10 | $8.13 | 23% |
| 2022-03-31 | 2 | $16 | $5 | $10.5 | $8.13 | 29.15% |
The Trend in the Analyst Price Target
Over the past 175 months, PRPH's average price target has gone up $2.5.
PRPH reports an average of 185.76% for its upside potential over the past 51 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-04-25 | 0 | 25 | 20 | 22.5 | 5.23 | 330.21% |
| 2021-05-22 | 0 | 25 | 20 | 22.5 | 6.37 | 253.22% |
| 2021-08-05 | 0 | 25 | 20 | 22.5 | 7.31 | 207.8% |
| 2021-09-11 | 0 | 20 | 9 | 14.5 | 5.66 | 156.18% |
| 2022-01-14 | 2 | 15 | 5 | 10.0 | 7.30 | 36.99% |
PRPH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 28 days, PRPH's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- ProPhase Labs Inc's number of analysts covering the stock is greater than 18.84% of all US stocks.
- PRPH has a lower variance in analysts' estimates than -172.29% of all US stocks.
- In terms of how ProPhase Labs Inc fares relative to all US stocks, note that its average analyst price target is greater than 30.55% of that group.
- In terms of how ProPhase Labs Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 32.33% of that group.
In the Pharmaceutical Products industry, PHIO, PCSA, and ORGS are the three stocks most similar to ProPhase Labs Inc regarding the price target and analyst recommendation information presented here.
Is PRPH a Buy, Hold or Sell? See the POWR Ratings now!